首頁 > 市場調查報告書 > 醫療設備

體外診斷

安全採血針市場規模、佔有率及成長分析（依產品類型、應用、最終用戶及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1897823

安全採血針市場規模、佔有率及成長分析（依產品類型、應用、最終用戶及地區分類）－2026-2033年產業預測

Safety Lancet Market Size, Share, and Growth Analysis, By Product Type (Push Button Safety Lancet, Pressure Activated Safety Lancet), By Application (Blood Glucose Testing, Haemoglobin Testing), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，安全採血針市場規模將達到 19.1 億美元，到 2025 年將達到 20.9 億美元，到 2033 年將達到 43.1 億美元，在預測期（2026-2033 年）內，複合年成長率為 9.5%。

安全採血針市場正經歷顯著擴張，主要促進因素是糖尿病和感染疾病發病率的上升。採血針正成為醫療保健機構不可或缺的工具，尤其是在血糖值監測和診斷方面。人們對更安全、更便利、更易用的單次使用採血採血針的需求正在飆升。在印度和中國等新興市場，醫療機構數量的增加和意識提升為採血針生產商帶來了巨大的成長機會。然而，挑戰依然存在，例如醫護人員可能因針刺傷而感染疾病。此外，重複使用採血針的風險也促使醫療機構加強安全措施，並推動一次性產品的更廣泛應用。

安全採血針市場促進因素

受糖尿病日益普遍這項全球性健康挑戰的推動，安全採血針市場正經歷顯著成長。預計這一趨勢將持續加速，1型和第2型糖尿病患者人數的不斷增加給全球醫療保健系統帶來了沉重的經濟負擔。造成這一趨勢的因素包括肥胖、吸煙和缺乏運動等不健康的生活方式，以及日益成長的都市化進程。此外，隨著人口老化，糖尿病的發病率預計將進一步上升，從而推動對安全採血針的需求，使其成為應對這一緊迫健康問題的必要解決方案。

安全採血針市場的限制

安全採血針市場的成長受到許多挑戰的限制，其中最顯著的是許多發展中地區對家用採血針的認知度較低。這種認知差距嚴重阻礙了那些本可從這些醫療設備中獲益匪淺的人群接受和使用家用採血針，以滿足其基本的診斷和監測需求。對家用採血針的益處和可及性缺乏了解限制了其普及，並成為該細分市場擴張的一大障礙。解決這些認知問題對於釋放安全採血針的潛力、改善醫療服務不足地區的醫療保健至關重要。

安全採血針市場趨勢

安全採血針市場正經歷顯著成長，這主要得益於提升用戶安全性和舒適度的創新技術發展。現代安全採血針配備了先進的功能，例如可伸縮裝置，可在使用後安全收納針頭，從而顯著降低針刺傷的風險。這種從傳統基礎設計到更先進、更人性化產品的演變，反映了醫療機構對病人安全和感染控制日益成長的重視。此外，糖尿病盛行率的上升以及對血糖自我監測系統需求的增加，進一步推動了市場動態，促使消費者尋求更安全、更有效率的採血解決方案。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Cardinal Health（United States）
Greiner Bio-One International GmbH（Austria）
Sarstedt AG & Co. KG（Germany）
Nipro Corporation（Japan）
Improve Medical Technology Co. Ltd.（China）
Simple Diagnostics（United States）
Ypsomed AG（Switzerland）
Owen Mumford Ltd.（United Kingdom）
Arkray Inc.（Japan）
Perrigo Company plc（Ireland）
Smiths Medical（United States）
Medline Industries, Inc.（United States）
Omron Healthcare, Inc.（Japan）
F. Hoffmann-La Roche AG（Switzerland）
Trinity Biotech（Ireland）
Microdot Healthcare（United Kingdom）
MED TRUST Holding Co.（Austria）
Nemaura Medical Inc.（United Kingdom）

結論與建議

簡介目錄

Product Code: SQMIG35A2818

Safety Lancet Market size was valued at USD 1.91 Billion in 2024 and is poised to grow from USD 2.09 Billion in 2025 to USD 4.31 Billion by 2033, growing at a CAGR of 9.5% during the forecast period (2026-2033).

The safety lancet market is experiencing significant expansion, largely fueled by the rising incidence of diabetes and infectious diseases. Lancets are increasingly essential in healthcare, particularly for blood glucose monitoring and diagnostics. Demand is soaring for user-friendly, single-use lancets that enhance safety and convenience. Emerging markets like India and China offer substantial growth prospects for lancet manufacturers, driven by an increase in healthcare facilities and heightened public awareness of health issues. However, challenges persist, notably concerns over needlestick injuries that threaten healthcare workers through potential infectious disease transmission. Additionally, the risks associated with reusing lancets underscore the shift towards adopting single-use options more broadly within healthcare settings, promoting safer practices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Safety Lancet market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Safety Lancet Market Segments Analysis

Global Safety Lancet Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Push Button Safety Lancet, Pressure Activated Safety Lancet and Side Button Safety Lancet. Based on Application, the market is segmented into Blood Glucose Testing, Haemoglobin Testing, Cholesterol Testing and Coagulation Testing. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Safety Lancet Market

The Safety Lancet market is experiencing remarkable growth, driven by the increasing prevalence of diabetes, a significant global health challenge that is expected to escalate over time. This rise in diabetes cases, encompassing both type 1 and type 2 variants, represents a considerable financial strain on healthcare systems across the globe. Factors contributing to this trend include unhealthy lifestyle choices such as obesity, smoking, lack of physical activity, and the ongoing trend of urbanization. Additionally, as the population ages, the incidence of diabetes is likely to rise, leading to a greater demand for safety lancets as a necessary solution to manage this pressing health issue.

Restraints in the Safety Lancet Market

The growth of the safety lancet market is hindered by several challenges, particularly the limited awareness surrounding homecare lancets in many developing regions. This gap in understanding significantly impedes the acceptance and utilization of these medical devices among individuals who could greatly benefit from them for essential diagnostic and monitoring needs. The insufficient knowledge about the advantages and availability of homecare lancets restricts their adoption, thereby posing a notable hurdle to the expansion of this market segment. Addressing these awareness issues is critical for unlocking the potential of safety lancets and improving healthcare accessibility in underserved areas.

Market Trends of the Safety Lancet Market

The safety lancet market is witnessing remarkable expansion, fueled by innovative technological developments that enhance user safety and comfort. Modern safety lancets now incorporate advanced features such as retractable mechanisms, which significantly reduce the risk of needlestick injuries by ensuring needles are safely contained after use. This evolution from traditional, basic designs to more advanced, user-friendly options reflects a growing emphasis on patient safety and infection control within healthcare settings. Additionally, the rising prevalence of diabetes and the demand for self-monitoring blood glucose systems further propel market dynamics, as consumers increasingly seek safer and more efficient blood collection solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Safety Lancet Market Size by Product Type & CAGR (2026-2033)

Market Overview
Push Button Safety Lancet
Pressure Activated Safety Lancet
Side Button Safety Lancet

Global Safety Lancet Market Size by Application & CAGR (2026-2033)

Market Overview
Blood Glucose Testing
Haemoglobin Testing
Cholesterol Testing
Coagulation Testing

Global Safety Lancet Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals and Clinics
Diagnostic Centers and Pathology Laboratories
Home Diagnostics
Others

Global Safety Lancet Market Size & CAGR (2026-2033)

North America (Product Type, Application, End User)
- US
- Canada
Europe (Product Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Cardinal Health (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Greiner Bio-One International GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sarstedt AG & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Improve Medical Technology Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Simple Diagnostics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arkray Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perrigo Company plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smiths Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medline Industries, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omron Healthcare, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microdot Healthcare (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MED TRUST Holding Co. (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nemaura Medical Inc. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments